European Parliament passes medical cannabis resolution, votes to relax laws and increase research into medical marijuana
13th Feb 2019
The European Parliament has today voted on a resolution that may determine if medical cannabis and cannabis oil can become more widely available for medicinal use in the countries that make up the European Union.
The resolution passed and will now be used to guide EU member states on their laws and practices regarding access to cannabinoid medicines.
The resolution seeks to encourage European Nations to facilitate ease of access to medical marijuana for citizens. It also advises that priority should be given to scientific research and clinical studies focused on studying the use of cannabis oil and cannabis extracts for treating patients with a variety of illnesses.
The EU resolution acknowledges the healing effects of medical cannabis oil when used for a wide variety of illnesses and disorders:
“there is evidence that cannabis or cannabinoids may be effective in increasing appetite and decreasing weight loss associated with HIV/AIDS, in alleviating symptoms of mental disorders such as psychosis or Tourette syndrome, and in alleviating symptoms of epilepsy, as well as Alzheimer’s, arthritis, asthma, cancer, Crohn’s disease and glaucoma, and that they also help to reduce the risk of obesity and diabetes and mitigate menstrual pain”
“a review of the existing scientific literature on the subject of cannabis used in a medical setting provides conclusive or substantial evidence that cannabis and cannabinoids have therapeutic effects, such as in the treatment of chronic pain in adults (e.g. in cancer disease cases), as anti-emetics for the treatment of chemotherapy-induced nausea and vomiting or for improving patient-reported multiple sclerosis spasticity symptoms, and are effective in the treatment of patients with anxiety disorders, PTSD and depression”
The acceptance by the EU Parliament that cannabis oil has a wide range of medicinal applications is extremely good news for tens of thousands of EU citizens who are currently unable to access cannabinoid medicines.
Most countries within the EU currently restrict cannabis oil prescriptions to a very small number of patients with very specific illnesses.
The European Parliament decision is in line with the recent advice from the World Health Organisation which is now promoting a much more relaxed and positive attitude towards cannabis oil and cannabis medications.
The EU Parliament is the latest of many official and regulatory bodies which have recently changed their stance on the use of cannabinoids. The resolution will be seen as a ray of hope by many citizens of European countries, many of whom are currently finding it difficult or impossible to acquire high-quality cannabis oil to treat medical problems. The EU resolution also calls for the relaxation of financial and regulatory barriers that have for many decades prevented scientific research into cannabis oils and cannabis extracts.
Other key points of the resolution:
- That international law and United Nations conventions do not prevent medical cannabis from being prescribed for specific conditions.
- The need to provide legal and safe access to medical cannabis for patients in need.
- That only one medical cannabis medicine is currently authorized by the EU.
- That cannabis medicine research has so far received zero funding from the EU.
- That there is no reliable information for EU Doctors, students, psychiatrists etc.
- Calls on member nations to stimulate research.
- Calls on member states to provide training in all aspects of medical cannabis.
Full text of the resolution can be found on the EU website here